Cite
HARVARD Citation
McFarland, E. et al. (2021). Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1–Exposed Newborn Infants. Journal of infectious diseases. pp. 1916-1924. [Online].